Bayer and Evotec Collaborate to Advance Precision Cardiology
Bayer and Evotec Collaborate to Advance Precision Cardiology
Stay updated with breaking news from Juergen Eckhardt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bayer and Evotec Collaborate to Advance Precision Cardiology
Bayer and Evotec have announced an expansion of their strategic collaboration towards innovative precision therapies for cardiovascular disease .The collaboration aims to identify and validate new...
EQS-News: Evotec SE / Key word: Miscellaneous Bayer and Evotec collaborate to advance precision cardiology 30.04.2024 / 08:30 CET/CEST The issuer is solely responsible...
The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...